Clinical and functional efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying the N1303K mutation
Ido Sadras, Eitan Kerem, Galit Livnat, Ifat Sarouk, Oded Breuer, Joel Reiter, Alex Gileles‐Hillel, Ori Inbar, Michael Cohen, Ayelet Gamliel, Noemie Stanleigh, T. Gunawardena, Claire Bartlett, Tanja Gonska, Theo J. Moraes, Paul D. W. Eckford, Christine E. Bear, Félix Ratjen, Batsheva Kerem, Michael Wilschanski, Michal Shteinberg, Malena Cohen‐Cymberknoh
Topics & Concepts
IvacaftorCystic fibrosisMedicineMutationInternal medicineIn vitroCystic fibrosis transmembrane conductance regulatorFrameshift mutationGastroenterologyBiologyGeneticsGeneCystic Fibrosis Research AdvancesNeonatal Respiratory Health ResearchAsthma and respiratory diseases